Последно актуализиране :
Стабилност и съвместимост на лекарства
Добре дошли в Stabilis. Ако желаете да получавате тримесечен бюлетин, въведете email адрес. Регистрирай се

Ако имате въпроси или коментари, моля свържете се с нас: infostab@stabilis.org
База данни  
Референции : 2648
Съединения : 811
Фармакологичен клас : 46
Стабилност на разтвори : 5894
Стабилност в смеси : 1187
Съвместимост : 11838
Търговско име : 4523
Новини - Съединения  
противораково лекарство Инжекция/Инжекционен Gemtuzumab ozogamicin 03/06/2021
Хормон Унгвент/Унгвенти Estrone 03/06/2021
Хормон Унгвент/Унгвенти Progestérone 03/06/2021
Хормон Унгвент/Унгвенти Testostérone 03/06/2021
противораково лекарство Инжекция/Инжекционен Pemetrexed diarginine 03/06/2021
Хормон Унгвент/Унгвенти Estradiol 01/06/2021
Антихипертензивно средство Орален разтвор Nicardipine hydrochloride 26/05/2021
Антикоагулант Инжекция/Инжекционен Nafamostat 19/04/2021
Хормон Инжекция/Инжекционен Thiamazole 09/03/2021
Анксиолитик Капсула Midazolam hydrochloride 03/03/2021
Други Инжекция/Инжекционен Turoctocog alfa 03/03/2021
Антибиотик Инжекция/Инжекционен Cefiderocol sulfate tosylate 03/03/2021
Антиаритмик Инжекция/Инжекционен Flecainide acetate 04/12/2020
Антибиотик Инжекция/Инжекционен Cefotiam 04/12/2020
Други Орален разтвор Carbimazole 01/12/2020
противораково лекарство Инжекция/Инжекционен Durvalumab 25/11/2020
Антибиотик Инжекция/Инжекционен Imipenem-Cilastatin / Relebactam 12/11/2020
противораково лекарство Инжекция/Инжекционен Avelumab 04/11/2020
Антибиотик Инжекция/Инжекционен Meropenem Vaborbactam 06/09/2020
Аналгетик Инжекция/Инжекционен Dezocine 05/09/2020
Новини - Референции  
Дата на влизане (въвеждане)
4578 Etude de stabilité de médicaments anticancéreux injectables : apports analytiques et pharmaceutiques 12/05/2021
4579 Application of the HPLC Method in Parenteral Nutrition Assessment: Stability Studies of Ondansetron Processes 12/05/2021
4575 Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Int J Pharm Compound 06/05/2021
4576 Stability of Extemporaneously-compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes. Int J Pharm Compound 06/05/2021
4577 Stability of Fagron's Phytobase Cream Compounded with Various Hormones. Int J Pharm Compound 06/05/2021
4572 Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures. Antibiotics 04/05/2021
4571 Levosimendan (Simdax 2.5 mg/ml) - Summary of Product Characteristics Orion Pharma 19/04/2021
4568 Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump. Journal of Chemotherapy 13/04/2021
4569 Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications. Hosp Pharm 13/04/2021
4570 Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Pharmaceuticals 13/04/2021
4567 Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study. Pharmaceutics 08/04/2021
4561 New liquid oral formulations of hydroxychloroquine: a physicochemical stability study. Pharmaceutical Technology in Hospital Pharmacy 07/04/2021
4563 Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children. Eur J Pharm Sci 07/04/2021
4556 The Physical Compatibility of Clinically Used Concentrations of Diltiazem Hydrochloride With Heparin Sodium. J Pharm Technol 24/03/2021
4559 Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration. Drug Design Dev Ther 24/03/2021
4546 Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags. EJHP 23/03/2021
4548 Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration. Clin Ther 23/03/2021
4550 The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration. Crit Care Resusc 23/03/2021
4545 Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment. Journal of Nippon Medical school 22/03/2021
4538 Compatibility of pentoxifylline and parenteral medications. Archives of Disease in Childhood 19/03/2021
4532 Atezolizumab (Tecentriq®) - Summary of Product Characteristics Roche Products Limited 25/02/2021
4529 Arsenic trioxide - Summary of Product Characteristics Accord Healthcare S.L.U. 23/02/2021
4528 Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 12/02/2021
4526 Stability of mitomycin in polypropylene syringes for use in glaucoma surgery. EJOP 02/02/2021
4525 Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions. Adv Ther 28/01/2021
4523 Formulation and stability study of hydroxychloroquine sulfate oral suspensions. Pharm Dev Technol 20/01/2021
4524 Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. ESCP Symposium, Geneva, Switzerland 20/01/2021
4522 Six months stability investigation of sufentanil and ropivacaine/levobupivacaine admixtures in plastic container by LC-UV. J Pharm Biomed Anal 19/01/2021
4521 Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 12/01/2021
4518 In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion. EJHP 06/01/2021

  Mentions Légales